A kinetic mechanism for the polymerization of α1-antitrypsin

被引:190
作者
Dafforn, TR
Mahadeva, R
Elliott, PR
Sivasothy, P
Lomas, DA
机构
[1] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England
[2] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Resp Med Unit, Cambridge CB2 2XY, England
关键词
D O I
10.1074/jbc.274.14.9548
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mutation in the Z deficiency variant of alpha(1)-antitrypsin perturbs the structure of the protein to allow a unique intermolecular linkage. These loop-sheet polymers are retained within the endoplasmic reticulum of hepatocytes to form inclusions that are associated with neonatal hepatitis, juvenile cirrhosis, and hepatocellular carcinoma. The process of polymer formation has been investigated here by intrinsic: tryptophan fluorescence, fluorescence polarization, circular dichroic spectra and extrinsic fluorescence with 8-anilino-1-naphthalenesulfonic acid and tetramethylrhodamine-5-iodoacetamide. These biophysical techniques have demonstrated that alpha(1)-antitrypsin polymerization is a two-stage process and have allowed the calculation of rates for both of these steps. The initial fast phase is unimolecular and likely to represent temperature-induced protein unfolding, while the slow phase is bimolecular and associated with loop-sheet interaction and polymer formation. The naturally occurring Z, S, and I variants and recombinant site-directed reactive loop and shutter domain mutants of alpha(1)-antitrypsin were used to demonstrate the close association between protein stability and rate of alpha(1)-antitrypsin polymerization, Taken together, these data allow us to propose a kinetic mechanism for alpha(1)-antitrypsin polymer formation that involves the generation of an unstable intermediate, which can form polymers or generate latent protein.
引用
收藏
页码:9548 / 9555
页数:8
相关论文
共 47 条
[1]   MECHANISMS CONTRIBUTING TO THE CONFORMATIONAL AND FUNCTIONAL FLEXIBILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, CJ ;
DECLERCK, PJ .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (10) :891-897
[2]  
AULAK KS, 1993, J BIOL CHEM, V268, P18088
[3]   CRYSTAL-STRUCTURE OF CLEAVED HUMAN ALPHA-1-ANTICHYMOTRYPSIN AT 2.7-A RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS [J].
BAUMANN, U ;
HUBER, R ;
BODE, W ;
GROSSE, D ;
LESJAK, M ;
LAURELL, CB .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (03) :595-606
[4]   CRYSTAL-STRUCTURE OF CLEAVED EQUINE LEUKOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95-ANGSTROM RESOLUTION [J].
BAUMANN, U ;
BODE, W ;
HUBER, R ;
TRAVIS, J ;
POTEMPA, J .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 226 (04) :1207-1218
[5]   MOLECULAR EVOLUTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FUNCTIONAL STABILITY [J].
BERKENPAS, MB ;
LAWRENCE, DA ;
GINSBURG, D .
EMBO JOURNAL, 1995, 14 (13) :2969-2977
[6]   THROMBOEMBOLIC DISEASE DUE TO THERMOLABILE CONFORMATIONAL-CHANGES OF ANTITHROMBIN ROUEN-VI (187-ASN-]ASP) [J].
BRUCE, D ;
PERRY, DJ ;
BORG, JY ;
CARRELL, RW ;
WARDELL, MR .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2265-2274
[7]  
BRUCH M, 1988, J BIOL CHEM, V263, P16626
[8]  
BUSBY TF, 1981, J BIOL CHEM, V256, P2140
[9]   PLAKALBUMIN, ALPHA-1-ANTITRYPSIN, ANTITHROMBIN AND THE MECHANISM OF INFLAMMATORY THROMBOSIS [J].
CARRELL, RW ;
OWEN, MC .
NATURE, 1985, 317 (6039) :730-732
[10]   Conformational disease [J].
Carrell, RW ;
Lomas, DA .
LANCET, 1997, 350 (9071) :134-138